Recombinant Shewanella baltica Elongation factor Ts (tsf)

What is Elongation factor Ts (EF-Ts) and what is its function in Shewanella baltica?

Elongation factor Ts (EF-Ts) is a protein that plays a critical role in the elongation phase of protein synthesis. In Shewanella baltica, as in other bacteria, EF-Ts functions as a guanine nucleotide exchange factor for elongation factor Tu (EF-Tu). It facilitates the exchange of GDP for GTP on EF-Tu, effectively recycling EF-Tu for subsequent rounds of aminoacyl-tRNA delivery to the ribosome during protein synthesis .

To study EF-Ts function experimentally, researchers should design nucleotide exchange assays that measure the rate of GDP/GTP exchange on EF-Tu in the presence and absence of EF-Ts. This can be accomplished using fluorescently labeled nucleotides or radioactive tracers. Comparing the activity of wild-type EF-Ts with targeted mutants can help identify critical residues involved in the EF-Tu interaction interface.

How is the tsf gene organized in bacterial genomes?

The tsf gene organization has been well-characterized in E. coli, providing a model for comparison with Shewanella baltica. In E. coli, the structural gene for elongation factor EF-Ts (tsf) and the gene for ribosomal protein S2 (rpsB) have been mapped near dapD at approximately 4 minutes on the E. coli genetic map . This location is distinct from the chromosomal regions where many other ribosomal protein genes and elongation factor genes (including fus, tufA, and tufB) are located .

For methodological analysis of tsf gene organization in Shewanella baltica or related species, researchers should employ comparative genomics approaches including whole-genome sequencing and synteny analysis. Phylogenetic analysis using concatenated sequences of conserved genes like rpoB and gyrB can establish evolutionary relationships between different Shewanella species, as has been demonstrated in previous studies .

What are the optimal storage and handling conditions for Recombinant Shewanella baltica EF-Ts?

Optimal storage of Recombinant Shewanella baltica EF-Ts requires maintaining the protein at -20°C, or at -20°C/-80°C for extended storage periods . Researchers should note that repeated freezing and thawing is not recommended as it may compromise protein integrity and activity. Working aliquots can be safely stored at 4°C for up to one week .

For proper handling, the following protocol is recommended:

• Briefly centrifuge the vial prior to opening to bring contents to the bottom

• Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (50% is the default recommendation) for long-term storage

• Prepare working aliquots to minimize freeze-thaw cycles

The shelf life of reconstituted protein varies depending on storage conditions: approximately 6 months for liquid formulations at -20°C/-80°C, and up to 12 months for lyophilized preparations at the same temperatures .

How can researchers verify the functionality of purified Recombinant Shewanella baltica EF-Ts?

Verifying the functionality of purified Recombinant Shewanella baltica EF-Ts requires multiple complementary approaches:

• Nucleotide Exchange Assay: The primary functional assay measures the ability of EF-Ts to catalyze GDP dissociation from EF-Tu. This can be quantified using fluorescently labeled nucleotides (mant-GDP) or radioactive nucleotides. An active EF-Ts will significantly increase the rate of GDP release compared to spontaneous dissociation .

• Binding Affinity Measurements: Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC) can determine the binding kinetics and thermodynamics of the EF-Ts/EF-Tu interaction. Functional EF-Ts should exhibit nanomolar affinity for EF-Tu-GDP.

• In vitro Translation Assays: Adding purified EF-Ts to a cell-free protein synthesis system should enhance translation efficiency in a concentration-dependent manner if the protein is functional.

• Structural Integrity Assessment: Circular Dichroism (CD) spectroscopy can verify proper folding by analyzing secondary structure content, while thermal shift assays can confirm stability under experimental conditions.

Research data should be analyzed by comparing activity parameters to published values for EF-Ts from well-characterized species, with appropriate statistical analysis of replicate experiments.

How does the expression and purification of Recombinant Shewanella baltica EF-Ts compare to other recombinant proteins?

Expression and purification of Recombinant Shewanella baltica EF-Ts presents both standard challenges and unique considerations. The recombinant protein is typically expressed in E. coli expression systems with achievable purity of >85% as assessed by SDS-PAGE . The full-length protein (283 amino acids) can be expressed without truncation .

Key methodological considerations include:

• Expression Optimization: Temperature, induction time, and inducer concentration should be systematically varied to maximize yield while maintaining solubility. Lower temperatures (16-25°C) often improve folding of recombinant proteins.

• Purification Strategy: The purification protocol typically involves affinity chromatography, with tag selection determined during manufacturing . Subsequent size exclusion chromatography may improve homogeneity.

• Buffer Optimization: The amino acid composition of Shewanella baltica EF-Ts may require specific buffer conditions to maintain stability and solubility. Researchers should test various pH values, salt concentrations, and additives.

• Quality Control: Rigorous quality assessment should include SDS-PAGE, mass spectrometry for identity confirmation, and functional assays to verify activity.

Unlike many other recombinant proteins, EF-Ts requires particular attention to its interaction with potential binding partners (specifically EF-Tu) when designing expression and purification strategies. Co-expression with EF-Tu may improve solubility in some cases.

What approaches can be used to study the interaction between Shewanella baltica EF-Ts and EF-Tu?

Studying the interaction between Shewanella baltica EF-Ts and EF-Tu requires multiple complementary techniques:

• Biochemical Interaction Assays:

  • Pull-down assays using tagged versions of either protein

  • Co-immunoprecipitation with specific antibodies

  • Size exclusion chromatography to isolate stable complexes

• Biophysical Characterization:

  • Surface Plasmon Resonance (SPR) for real-time interaction kinetics

  • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

  • Fluorescence Anisotropy to measure binding in solution

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to map interaction interfaces

• Functional Assays:

  • Nucleotide exchange assays measuring GDP/GTP exchange rates

  • Competition assays with known EF-Tu binding partners

  • Translation elongation rate measurements in reconstituted systems

• Structural Studies:

  • X-ray crystallography of the EF-Ts/EF-Tu complex

  • Cryo-electron microscopy for larger assemblies

  • NMR for dynamic aspects of the interaction

Data analysis should involve fitting to appropriate binding models (typically 1:1 Langmuir binding) and comparison with published parameters for model organisms. Controls should include mutated versions of either protein to validate specificity of the interaction.

What challenges exist in comparing gene expression patterns of tsf across different Shewanella species?

Comparing tsf gene expression across Shewanella species presents several methodological challenges:

• Genomic Diversity: Shewanella species exhibit significant genomic variability, as evidenced by whole-genome phylogenetic analyses . This diversity may affect primer design and amplification efficiency in expression studies.

• Reference Gene Selection: Appropriate reference genes for qRT-PCR normalization may vary between species, necessitating validation of stable reference genes for each species under study.

• Environmental Adaptation: Different Shewanella species inhabit diverse ecological niches with varying temperature, pressure, and salinity conditions, potentially affecting baseline tsf expression levels.

• Regulatory Elements: Promoter regions and regulatory mechanisms may differ across species, complicating direct comparisons of expression patterns.

Methodologically, researchers should:

• Employ RNA-seq for comprehensive transcriptome analysis

• Validate species-specific qRT-PCR primers and reference genes

• Analyze promoter regions to identify regulatory differences

• Use reporter gene constructs to directly compare promoter activity

• Standardize growth conditions to minimize environmental variables

Statistical analysis should account for inter-species variation and employ appropriate normalization methods to enable meaningful comparisons despite these challenges.

How can Recombinant Shewanella baltica EF-Ts be utilized in structural biology studies?

Utilizing Recombinant Shewanella baltica EF-Ts in structural biology studies requires specific methodological approaches:

• X-ray Crystallography:

  • High-purity protein (>95%) is typically required

  • Crystallization screening should test hundreds of conditions varying precipitants, buffers, and additives

  • Co-crystallization with binding partners (EF-Tu) may stabilize flexible regions

  • Resolution of 2.5Å or better is desirable for detailed structural analysis

• Cryo-Electron Microscopy:

  • Particularly valuable for studying EF-Ts in complexes with translation machinery

  • Sample preparation should focus on particle homogeneity and concentration

  • Single-particle analysis can achieve near-atomic resolution for stable complexes

• Nuclear Magnetic Resonance (NMR):

  • Requires isotope-labeled protein (13C, 15N)

  • Best suited for studying dynamic regions and domain movements

  • Can map binding interfaces through chemical shift perturbation experiments

• Small-Angle X-ray Scattering (SAXS):

  • Provides low-resolution structural information in solution

  • Useful for analyzing conformational changes upon binding

  • Complements high-resolution techniques

• Computational Modeling:

  • Homology modeling based on related structures

  • Molecular dynamics simulations to study conformational flexibility

  • Docking studies to predict interaction modes with binding partners

Data analysis should integrate results from multiple techniques to build a comprehensive structural model. Validation should include biochemical experiments testing predictions derived from structural studies.

What bioinformatic tools are most useful for analyzing Shewanella baltica tsf gene and its products?

Comprehensive bioinformatic analysis of the Shewanella baltica tsf gene and EF-Ts protein requires multiple specialized tools:

• Sequence Analysis Tools:

  • BLAST: For identifying homologous sequences across species

  • Clustal Omega or MUSCLE: For multiple sequence alignment

  • MEGA or PhyML: For phylogenetic tree construction and evolutionary analysis

  • WebLogo: For visualizing sequence conservation patterns

• Structural Analysis Tools:

  • AlphaFold or I-TASSER: For protein structure prediction

  • PyMOL or UCSF Chimera: For structural visualization and analysis

  • DSSP: For secondary structure assignment

  • ConSurf: For mapping evolutionary conservation onto structure

• Functional Prediction Tools:

  • InterProScan: For domain identification

  • SIFT or PolyPhen: For predicting effects of amino acid substitutions

  • STRING: For protein-protein interaction network analysis

• Genomic Context Analysis:

  • Artemis: For genome visualization

  • BAGET or SyntTax: For synteny analysis

  • MEME Suite: For motif discovery in regulatory regions

• Databases:

  • UniProt (ID: A3D2K6): For annotated protein information

  • PDB: For structural data

  • KEGG: For metabolic pathway context

  • PATRIC: For comparative genomics

Data integration is crucial, as no single tool provides complete information. Results should be critically evaluated based on statistical confidence measures and biological plausibility.

How should researchers interpret discrepancies in experimental results when working with Recombinant Shewanella baltica EF-Ts?

When encountering discrepancies in experimental results with Recombinant Shewanella baltica EF-Ts, researchers should systematically evaluate potential sources of variation:

• Protein Quality Factors:

  • Verify purity (should be >85% by SDS-PAGE)

  • Check for degradation using SDS-PAGE or mass spectrometry

  • Assess activity through functional assays

  • Consider lot-to-lot variability in commercial preparations

• Experimental Conditions:

  • Evaluate buffer composition effects (pH, salt concentration, additives)

  • Assess temperature sensitivity and stability

  • Consider the impact of freeze-thaw cycles on activity

  • Examine the influence of protein concentration on activity or aggregation state

• Methodological Considerations:

  • Compare technical details across experiments (equipment, reagents, protocols)

  • Evaluate differences in detection methods and their sensitivity

  • Consider the impact of tags or fusion partners on protein behavior

  • Assess the influence of binding partners or competitors in the experimental system

• Statistical Analysis:

  • Determine if observed differences are statistically significant

  • Calculate effect sizes to assess biological relevance

  • Consider power analysis to ensure adequate sample size

  • Implement appropriate controls to isolate variables

Creating a systematic troubleshooting flowchart and maintaining detailed laboratory records can help identify patterns in discrepancies and lead to resolution of conflicting results.

How can researchers determine the specificity and cross-reactivity of antibodies against Shewanella baltica EF-Ts?

Determining antibody specificity and cross-reactivity against Shewanella baltica EF-Ts requires systematic validation:

• Western Blot Analysis:

  • Test against purified recombinant Shewanella baltica EF-Ts

  • Include negative controls (unrelated proteins) and positive controls

  • Evaluate detection limits and linear range of signal response

  • Assess recognition of denatured vs. native protein

• Immunoprecipitation:

  • Test ability to pull down EF-Ts from Shewanella baltica lysates

  • Confirm identity of precipitated proteins by mass spectrometry

  • Evaluate efficiency under various buffer conditions

• Cross-Reactivity Assessment:

  • Test against EF-Ts from related Shewanella species

  • Evaluate recognition of EF-Ts from distant bacterial genera

  • Perform peptide competition assays to confirm epitope specificity

• Epitope Mapping:

  • Use peptide arrays or phage display to identify recognized epitopes

  • Compare epitope sequences across species to predict cross-reactivity

  • Generate epitope-specific antibodies for improved specificity

• Application-Specific Validation:

  • Validate for specific applications (Western blot, ELISA, immunofluorescence)

  • Determine optimal antibody concentrations for each application

  • Evaluate performance in the presence of potential interfering substances

Data analysis should include quantitative measurements of signal-to-noise ratio and statistical comparison across conditions. Antibody characterization should follow established guidelines for reproducibility and reliability.

How can Recombinant Shewanella baltica EF-Ts be used in antibiotic development research?

Recombinant Shewanella baltica EF-Ts offers several valuable applications in antibiotic development research:

• Target Identification and Validation:

  • EF-Ts participates in a critical step of protein synthesis, making it a potential antibiotic target

  • Structural and functional comparison with EF-Ts from pathogenic bacteria can identify conserved targetable features

  • Essentiality studies can validate EF-Ts as a viable target

• High-Throughput Screening:

  • Develop assays measuring nucleotide exchange activity for compound library screening

  • Establish fluorescence-based assays suitable for microplate format

  • Create differential screening approaches to identify compounds selective for pathogen EF-Ts over human mitochondrial EF-Ts

• Structure-Based Drug Design:

  • Use crystal structures or computational models to identify binding pockets

  • Design compounds targeting the EF-Ts/EF-Tu interface

  • Perform in silico docking studies to prioritize candidate compounds

• Resistance Mechanism Studies:

  • Investigate potential resistance mechanisms through directed evolution experiments

  • Study horizontal gene transfer of resistance determinants, similar to studies on CTX-M-15-producing Shewanella species

  • Evaluate the frequency of resistance-conferring mutations

• Alternative Translation Machinery Targeting:

  • Compare with other translation factors as potential antibiotic targets

  • Evaluate synergistic effects with existing translation-targeting antibiotics

  • Develop multi-target approaches to minimize resistance development

Data analysis should include standard pharmacological parameters (IC50/EC50), selectivity indices, and structure-activity relationship modeling to guide compound optimization.

What role does Shewanella baltica EF-Ts play in environmental adaptation and stress response?

Investigating the role of Shewanella baltica EF-Ts in environmental adaptation and stress response requires multiple experimental approaches:

• Expression Analysis Under Stress Conditions:

  • Quantify tsf transcription under various stressors (temperature, salinity, pH, oxidative stress)

  • Measure EF-Ts protein levels using quantitative proteomics

  • Analyze potential post-translational modifications under stress conditions

• Genetic Manipulation Studies:

  • Create conditional tsf mutants (as complete deletion may be lethal)

  • Evaluate growth phenotypes under various stress conditions

  • Perform complementation studies with wild-type and mutant alleles

• Protein Function Under Stress:

  • Measure nucleotide exchange activity at different temperatures and pH values

  • Assess protein stability under varying environmental conditions

  • Evaluate changes in EF-Ts/EF-Tu interaction parameters under stress

• Comparative Analysis Across Shewanella Species:

  • Compare tsf sequences from Shewanella species adapted to different environments

  • Correlate sequence variations with habitat-specific adaptations

  • Analyze expression patterns across species under standardized conditions

• Global Response Network Analysis:

  • Place EF-Ts in the context of global stress response networks

  • Identify regulatory factors controlling tsf expression

  • Map protein-protein interactions that change under stress conditions

This research is particularly relevant for Shewanella species, which inhabit diverse environments and demonstrate remarkable metabolic versatility, potentially requiring specialized translation machinery adaptations.

How can researchers utilize Recombinant Shewanella baltica EF-Ts in comparative studies with clinical bacterial isolates?

Recombinant Shewanella baltica EF-Ts provides a valuable reference point for comparative studies with clinical bacterial isolates:

• Functional Comparison Studies:

  • Compare nucleotide exchange kinetics between Shewanella baltica EF-Ts and EF-Ts from clinical isolates

  • Assess temperature optima and pH sensitivity differences

  • Evaluate inhibitor sensitivity profiles across species

• Cross-Species Complementation:

  • Test if Shewanella baltica EF-Ts can functionally replace EF-Ts in clinical isolates

  • Create chimeric proteins to map species-specific functional domains

  • Evaluate translation efficiency with heterologous EF-Ts proteins

• Evolutionary Analysis:

  • Perform phylogenetic analysis of tsf sequences across environmental and clinical isolates

  • Identify signatures of selection in different bacterial lineages

  • Trace the evolution of antibiotic resistance-associated features

• Structural Comparisons:

  • Compare structural features that might contribute to differential antibiotic sensitivity

  • Identify conserved epitopes for potential diagnostic development

  • Map species-specific surface features for targeted intervention

• Application in Diagnostic Development:

  • Assess potential of EF-Ts as a biomarker for Shewanella infections

  • Develop specific antibodies or aptamers for detection purposes

  • Create rapid diagnostic tests based on EF-Ts sequence or structural features

This comparative approach is particularly relevant given the emergence of clinical Shewanella isolates with antibiotic resistance determinants, such as the CTX-M-15-producing Shewanella species described in recent literature .